Company Filing History:
Years Active: 2014-2019
Title: Innovations of Hongmei Mo in Hepatitis C Treatment
Introduction
Hongmei Mo is a prominent inventor based in Palo Alto, CA, known for her significant contributions to the field of medicine, particularly in the treatment of hepatitis C virus (HCV) infection. With a total of 7 patents, her work has been instrumental in developing effective therapeutic methods and compositions.
Latest Patents
Among her latest patents, Mo has developed methods for treating HCV, which involve combinations of therapeutic molecules. This invention focuses on various methods, uses, dosing regimens, and compositions that are crucial for combating hepatitis C virus infection. Another notable patent discloses a composition and unit dosage form for treating HCV, which includes GS-7977 and at least one pharmaceutically acceptable excipient. The methods outlined in her patents also include administering an effective amount of GS-7977 and ribavirin to infected subjects, aiming to achieve an undetectable amount of HCV RNA for at least 12 weeks post-treatment.
Career Highlights
Throughout her career, Hongmei Mo has worked with leading companies in the pharmaceutical industry, including Gilead Pharmasset LLC and Gilead Sciences, Inc. Her innovative approaches and dedication to research have positioned her as a key figure in the development of antiviral therapies.
Collaborations
Mo has collaborated with notable professionals in her field, including Adrian S. Ray and William E. Delaney, IV. These collaborations have further enhanced her research and contributed to the advancement of treatment options for hepatitis C.
Conclusion
Hongmei Mo's contributions to the field of hepatitis C treatment through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for innovative solutions in combating viral infections.